| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/09/2000 | EP0977741A1 Substituted phenyl derivatives, their preparation and use |
| 02/09/2000 | EP0977738A2 Cyclin dependent kinase (cdk)4 inhibitors and their use for treating cancer |
| 02/09/2000 | EP0977737A1 Crf antagonistic quino- and quinazolines |
| 02/09/2000 | EP0977735A1 Vitronectin receptor antagonists |
| 02/09/2000 | EP0977734A2 Arylsecocholadiene derivatives |
| 02/09/2000 | EP0977733A1 Arylsulfonylamino hydroxamic acid derivatives |
| 02/09/2000 | EP0977725A1 New fatty acid derivatives |
| 02/09/2000 | EP0977597A4 Improved methods for diagnostic imaging using a contrast agent and a vasodilator |
| 02/09/2000 | EP0977597A1 Improved methods for diagnostic imaging using a contrast agent and a vasodilator |
| 02/09/2000 | EP0977595A1 Prevention of graft-versus-host disease with t-cells including polynucleotides encoding negative selective markers |
| 02/09/2000 | EP0977593A1 Embolus therapy using insoluble microparticles or vesicles containing contrast agents |
| 02/09/2000 | EP0977585A1 Methods for diagnosing and treating body weight related disorders in animals |
| 02/09/2000 | EP0977582A1 Pharmaceutical combined preparations containing erythropoietin and iron preparations |
| 02/09/2000 | EP0977578A1 Compositions to enhance the cytoprotective effects of polycyclic phenolic compounds through the synergistic interaction with anti-oxidants |
| 02/09/2000 | EP0977577A1 Compositions for the treatment of ards or irds containing 3-(cyclopropylmethoxy)-n-(3,5-dichloro-4-pyridinyl)-4-(difluoromethoxy)benzamide and lung surfactant |
| 02/09/2000 | EP0977576A1 Osteoblast-promoting pharmaceutical composition comprising a carnitine compound and dhea or dhea-s |
| 02/09/2000 | EP0977575A1 THE USE OF $g(a)-METHYL-P-TYROSINE TO INHIBIT MELANIN PRODUCTION IN IRIS MELANOCYTES |
| 02/09/2000 | EP0977574A1 Methods for in vivo reduction of cyanide levels and compositions useful therefor |
| 02/09/2000 | EP0977573A1 Use of an nk-1 receptor antagonist and an ssri for treating obesity |
| 02/09/2000 | EP0977572A1 Use of nk-1 receptor antagonists for treating eating disorders |
| 02/09/2000 | EP0977571A1 Piperazine derivatives for treating bone deficit conditions |
| 02/09/2000 | EP0977570A1 Quinoxaline in triple combination with protease inhibitors and reverse transcriptase inhibitors as medicines for treating aids |
| 02/09/2000 | EP0977569A1 Pharmaceutical composition for supressing type 2 helper t cell immune response |
| 02/09/2000 | EP0977568A1 Benzocycloheptathiophene compounds |
| 02/09/2000 | EP0977567A1 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment |
| 02/09/2000 | EP0977566A1 Method for the treatment of stroke using n-heterocyclic glyoxylamide compounds |
| 02/09/2000 | EP0977565A1 Pharmaceutical composition |
| 02/09/2000 | EP0977564A1 Forskohlin for promoting lean body mass |
| 02/09/2000 | EP0977563A1 Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
| 02/09/2000 | EP0977562A1 Methods and compositions for delivery of taxanes |
| 02/09/2000 | EP0977561A1 Glucosamine fatty acid compositions and their use |
| 02/09/2000 | EP0977560A1 IBUPROFEN THIOESTERS AS INHIBITORS OF Nf-kappaB-DEPENDENT PAIN AND INFLAMMATION MEDIATOR FORMATION |
| 02/09/2000 | EP0977559A1 Enhanced anti-cancer agent delivery to solid tumors by primer compounds |
| 02/09/2000 | EP0977558A2 Use of 5ht4 receptor antagonists for overcoming gastrointestinal effects of serotonin reuptake inhibitors |
| 02/09/2000 | EP0977557A1 Pellet-type formulation intended for treating the intestinal tract |
| 02/09/2000 | EP0977555A1 Pharmaceutical preparations and methods for their regional administration |
| 02/09/2000 | EP0977554A1 Confectionery compositions |
| 02/09/2000 | EP0977553A1 Throat soothing compositions |
| 02/09/2000 | EP0977552A1 Composition for topical application on the skin and/or its appendages comprising at least a compound containing an iminophenol fragment |
| 02/09/2000 | EP0977544A1 Personal care compostions comprising a silicone-containing adhesive copolymer |
| 02/09/2000 | EP0977484A1 Non-spherical and non-platelet pyrithione salts |
| 02/09/2000 | EP0977482A1 IDENTIFICATION OF POLYNUCLEOTIDES ENCODING NOVEL $i(HELICOBACTER) POLYPEPTIDES IN THE $i(HELICOBACTER) GENOME |
| 02/09/2000 | EP0828434B1 Fat based food products |
| 02/09/2000 | EP0793671B1 Phenylsubstituted 4-azasteroid fluoroderivatives |
| 02/09/2000 | EP0771200B1 Use of raloxifene and its analogs for the manufacture of a medicament for the treatment of viral diseases |
| 02/09/2000 | EP0746332B1 Dna encoding a human neuropeptide y/peptide yy/pancreatic polypeptide receptor (y4) and uses thereof |
| 02/09/2000 | CN1244213A Pressure-mediated intracellular delivery of molecules or microparticles |
| 02/09/2000 | CN1244202A Tricyclic erythromycin derivatives |
| 02/09/2000 | CN1244197A Tetrahydrofuran derivatives |
| 02/09/2000 | CN1244196A 3-amino-1,2-benzoisoxazole derivatives, process for preparation,a nd use thereof |
| 02/09/2000 | CN1244193A Novel amide derivatives and medicinal compositions thereof |
| 02/09/2000 | CN1244129A Useof dimeticone as transport and carrier system and/or drug delevery system |
| 02/09/2000 | CN1244125A Use of cis-hydroxyitraconazole in order to advoid side-effects of itraconazole and hydroxyintraconazole |
| 02/09/2000 | CN1244124A Amorphous benzothiophenes, methods of preparation, and methods of use |
| 02/09/2000 | CN1244123A Kit for inhibiting the growth of cancers, comprising a chemotherapeutic agent and a benzimdazole, and optionally a protentiator |
| 02/09/2000 | CN1244122A Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia |
| 02/09/2000 | CN1244121A Viral inhibition by long-chain alcohols, alkanes, fatty acids and amides |
| 02/09/2000 | CN1244120A New formulation for inhalation having a poured bulk density of from 0.28 to 0.38 G/ml, comprising terbutaline sulphate, a process for preparing the formulation and the use thereof |
| 02/09/2000 | CN1243827A Preparation of heterocyclic amide derivative with specific physical status |
| 02/09/2000 | CN1243826A Antihypertensive and anticancer compound, its preparing process and its application in medicine |
| 02/09/2000 | CN1243749A Inhibitor |
| 02/09/2000 | CN1243724A Oral medicine for treating dermatosis |
| 02/09/2000 | CN1243723A Quickly-acting antalgic ointment |
| 02/09/2000 | CN1243715A Medicine for treating piles and its preparing process |
| 02/09/2000 | CN1243704A Quickly-acting analgesic |
| 02/09/2000 | CN1243701A Use of cholesterol liquid crystal composition in cosmetics and pharmaceutical preparation |
| 02/09/2000 | CN1049222C Propiophenone derivative and processes for preparing the same |
| 02/09/2000 | CN1049221C Ginseng oligosaccharide element and ginseng monomer oligosaccharide and its preparing technology and use |
| 02/09/2000 | CN1049219C Fused heteroaromatic cyclopentene derivative having endothelin-antagonist activity |
| 02/09/2000 | CN1049217C 1,5-benzodiazepine derivatives |
| 02/09/2000 | CN1049215C Pharmaceutical compounds |
| 02/09/2000 | CN1049214C Phenylimidazolidines, process for their preparation, their use as medicament and pharmaceutical compositions containing them. |
| 02/09/2000 | CN1049145C Sterilizing liquid keyanshu for woman |
| 02/09/2000 | CN1049138C Antiphlogistic and analgesic liquid for treatment of spur |
| 02/09/2000 | CN1049129C Antidiarrheal |
| 02/09/2000 | CN1049117C Tablet for preventing and curing migraine |
| 02/09/2000 | CN1049116C Process for treating cardiovascular hypertrophy and hyperplasia |
| 02/09/2000 | CN1049115C Compound preparation for preventing heart lung and brain hypoxia injury and its producing method |
| 02/08/2000 | USRE36562 Fungicides for the control of take-all disease of plants |
| 02/08/2000 | US6022996 Method for making intermediates useful in synthesis of retroviral protease inhibitors |
| 02/08/2000 | US6022994 Succinoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 02/08/2000 | US6022985 Process for the preparation of 4-acetoxy-2α-benzoyloxy-5β, 20-epoxy-1, 7β-10β-trihydroxy-9-oxo-tax-11-en-13α-yl(2R,3S)-3-tert-b utoxy-carbonYlamino-2-hydroxy-3-phenylpropionate trihydrate |
| 02/08/2000 | US6022984 Efficient synthesis of furan sulfonamide compounds useful in the synthesis of new IL-1 inhibitors |
| 02/08/2000 | US6022983 Preparing a myxopyronin |
| 02/08/2000 | US6022981 Key intermediates in synthesizing 5,10-disubstituted porphyrin compounds or other 5,10-disubstituted polypyrrolic macrocycles. |
| 02/08/2000 | US6022978 Benzimidazole derivatives |
| 02/08/2000 | US6022971 Azetidines |
| 02/08/2000 | US6022969 Symmetrical bis(aminoalkyl), bis(amidinoalkyl) and bis(guanidinoalkyl) cycloalkanes |
| 02/08/2000 | US6022965 Reacting a compound of the alpha isomer or mixture of alpha and beta isomers with basic reagent to produce beta isomer |
| 02/08/2000 | US6022901 Administration of resveratrol to prevent or treat restenosis following coronary intervention |
| 02/08/2000 | US6022900 Preventing and ameliorating cachexia; treating whole body nitrogen loss associated with catabolic illness by inhibiting synthesis of urea from plasma arginine |
| 02/08/2000 | US6022899 Effective inhibitors of the cellular sodium proton antiporter |
| 02/08/2000 | US6022898 Metalloproteinase inhibitors |
| 02/08/2000 | US6022897 Selective modulators of peroxisome proliferator activated receptor-gamma, and methods for the use thereof |
| 02/08/2000 | US6022896 Petroselinic acid as an anti-irritant in compositions containing alpha-hydroxy acids |
| 02/08/2000 | US6022895 Substituted amino compounds and their use as substances having an analgesic effect |
| 02/08/2000 | US6022894 Method of using calcilytic compounds |
| 02/08/2000 | US6022892 Bis-platinum complexes with polyamine ligands as antitumor agents |
| 02/08/2000 | US6022889 Pharmaceutical preparations containing bilobalide for the treatment of tension and anxiety |
| 02/08/2000 | US6022887 Compositions and methods for stimulating bone growth |